MiR-93 Controls Adiposity via Inhibition of Sirt7 and Tbx3
Author(s) -
Michele Cioffi,
Mireia Vallespinos-Serrano,
Sara Trabulo,
Pablo J. Fernández-Marcos,
Ashley Firment,
Berta N. Vázquez,
Catarina R. Vieira,
Francisca Mulero,
Juan A. Cámara,
Ultan P. Cronin,
Manuel PérezMartínez,
Joaquím Soriano,
Beatriz G. Gálvez,
Álvaro Castells-García,
Verena Haage,
Deepak B. Thimiri Govinda Raj,
Diego Megı́as,
Stephan A. Hahn,
Lourdes Serrano,
Anne Moon,
Alexandra Aicher,
Christopher Heeschen
Publication year - 2015
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2015.08.006
Subject(s) - medicine , biology , endocrinology
Conquering obesity has become a major socioeconomic challenge. Here, we show that reduced expression of the miR-25-93-106b cluster, or miR-93 alone, increases fat mass and, subsequently, insulin resistance. Mechanistically, we discovered an intricate interplay between enhanced adipocyte precursor turnover and increased adipogenesis. First, miR-93 controls Tbx3, thereby limiting self-renewal in early adipocyte precursors. Second, miR-93 inhibits the metabolic target Sirt7, which we identified as a major driver of in vivo adipogenesis via induction of differentiation and maturation of early adipocyte precursors. Using mouse parabiosis, obesity in mir-25-93-106b(-/-) mice could be rescued by restoring levels of circulating miRNA and subsequent inhibition of Tbx3 and Sirt7. Downregulation of miR-93 also occurred in obese ob/ob mice, and this phenocopy of mir-25-93-106b(-/-) was partially reversible with injection of miR-93 mimics. Our data establish miR-93 as a negative regulator of adipogenesis and a potential therapeutic option for obesity and the metabolic syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom